The minimally important difference for patient-reported outcomes in spondyloarthropathies including pain, fatigue, sleep, and health assessment questionnaire

Journal of Rheumatology

Volumn 37, Issue 4, 2010, Pages 816-822

  Wheaton, Laura ^a   Pope, Janet ^a  

^a WESTERN UNIVERSITY   (Canada)

Author keywords

Ankylosing spondylitis; Health assessment questionnaire; Minimally important difference; Patient outcomes; Seronegative spondyloarthropathy; Visual analog scale

Indexed keywords

METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR;

ADULT; ARTHRITIS; ARTICLE; CLINICAL ASSESSMENT; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DISEASE DURATION; FATIGUE; FEMALE; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINIMALLY IMPORTANT DIFFERENCE; OUTCOME ASSESSMENT; PAIN; PRIORITY JOURNAL; QUALITY CONTROL; SELF CONCEPT; SELF REPORT; SLEEP; SPONDYLOARTHROPATHY; VISUAL ANALOG SCALE;

ACTIVITIES OF DAILY LIVING; ADULT; FATIGUE; FEMALE; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; PAIN; PAIN MEASUREMENT; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; SLEEP; SPONDYLARTHROPATHIES;

EID: 77950675817     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.090086     Document Type: Article

References (37)

1. Martindale J, Smith J, Sutton CJ, Grennan D, Goodacre L, Goodacre JA. Disease and psychological status in ankylosing spondylitis. Rheumatology 2006;45:1288-1293 (Pubitemid 44542072)
2. Forouzesh S, Bluestone R. The clinical spectrum of ankylosing spondylitis. Clin Orthop Relat Res 1979;143:53-58
3. Haywood KL, Garratt AM, Jordan K, Dziedzic K, Dawes PT. Disease-specific, patient-assessed measures of health outcome in ankylosing spondylitis: reliability, validity and responsiveness. Rheumatology 2002;41:1295-1302 (Pubitemid 35363805)
4. Haywood KL, Garratt AM, Dziedzic K, Dawes PT. Generic measures of health-related quality of life in ankylosing spondylitis: reliability, validity and responsiveness. Rheumatol 2002;41:1380-1387 (Pubitemid 36004314)
5. Ward MM, Weisman MH, Davis JC, Reveille JD. Risk factors for functional limitations in patients with long-standing ankylosing spondylitis. Arthritis Rheum 2005;53:710-717 (Pubitemid 41463836)
6. Turan Y, Duruoz MT, Bal S, Guvenc A, Cerrahoglu L, Gurgan A. Assessment of fatigue in patients with ankylosing spondylitis. Rheumatol Int 2007;27:847-852 (Pubitemid 46906646)
7. Borman P. Functional disability and quality of life in patients with ankylosing spondylitis. Rheumatol Int 2004;24:59-60. (Pubitemid 38168119)
8. Haywood KL, Garratt AM, Dziedzic K, Dawes PT. Patient centered assessment of ankylosing spondylitis-specific health related quality of life: evaluation of the patient generated index. J Rheumatol 2003;30:764-773 (Pubitemid 36402771)
9. Dernis-Labous E, Messow M, Dougados M. Assessment of fatigue in the management of patients with ankylosing spondylitis. Rheumatology 2003;42:1523-1528 (Pubitemid 37508927)
10. Khanna D, Pope J, Khanna PP, Maloney M, Samedi N, Norrie D, et al. The minimally important difference for the fatigue visual analog scale in patients with rheumatoid arthritis followed in an academic clinical practice. J Rheumatol 2008;35:2339-2343
11. Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980;23:137-145
12. Wolfe F, Michaud K, Gefellar O, Choi HK. Predicting mortality in patients with rheumatoid arthritis. Arthritis Rheum 2003;48:1530-1542 (Pubitemid 36682360)
13. Daltroy LH, Larson MG, Roberts NW, Liang MH. A modification of the Health Assessment Questionnaire for the spondyloarthropathies. J Rheumatol 1990;17:946-950 (Pubitemid 20243735)
14. Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease activity in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994;21:2286-2291
15. Calin A, Garrett S, Whitelock H, Kennedy LG, O'Hea J, Mallorie P, et al. A new approach to defining functional ability in ankylosing spondytitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 1994;21:2281-2285
16. Jaeschke R, Singer J, Guyatt GH. Measurement of health status: ascertaining the minimal clinically important difference. Control Clin Trials 1989;10:407-415 (Pubitemid 20025670)
17. Crosby RD, Kolotkin RL, Williams GR. Defining clinically meaningful change in health-related quality of life. J Clin Epidemiol 2003;56:395-407.
18. Falgarone G, Zerkak D, Bauer C, Messow M, Dougados M. How to define a minimal clinically individual state (MCIS) with pain VAS in daily practice for patients suffering from musculoskeletal disorders. Clin Exp Rheumatol 2005;23:235-238 (Pubitemid 40663006)
19. Maksymowych WP, Richardson R, Mallon C, van der Heijde D, Boonen A. Evaluation and validation of the patient acceptable symptom state (PASS) in patients with ankylosing spondylitis. Arthritis Rheum 2007;57:133-139 (Pubitemid 46256735)
20. Tubach F, Pham T, Skomsvoll JF, Mikkelsen K, Bjorneboe O, Ravaud P, et al. Stability of the patient acceptable symptomatic state over time in outcome criteria in ankylosing spondylitis. Arthritis Rheum 2006;55:960-963
21. Dougados M, Luo MP, Maksymowych WP, Chmiel JJ, Chen N, Wong RL, et al. Evaluation of the patient acceptable symptom state as an outcome measure in patients with ankylosing spondylitis: data from a randomized controlled trial. Arthritis Rheum 2008;59:553-560
22. Pavy S, Brophy S, Calin A. Establishment of the minimum clinically important difference for the Bath ankylosing spondylitis indices: a prospective study. J Rheumatol 2005;32:80-85 (Pubitemid 40092596)
23. Kosinski M, Zhao SZ, Dedhiya S, Osterhaus JT, Ware JE Jr. Determining minimally important changes in generic and disease-specific health-related quality of life questionnaires in clinical trials of rheumatoid arthritis. Arthritis Rheum 2000;43:1478-1487 (Pubitemid 30452465)
24. Salaffi F, Stancati A, Silvestri CA, Ciapetti A, Grassi W. Minimal clinically important changes in chronic musculoskeletal pain intensity measured on a numerical rating scale. Eur J Pain 2004;8:283-291 (Pubitemid 38859657)
25. Pope JE, Khanna D, Norrie D, Ouimet J. The minimally important difference for the Health Assessment Questionnaire in rheumatoid arthritis clinical practice is smaller than in randomized controlled trials. J Rheumatol 2009;36:254-259
26. Cohen J. A power primer. Psychol Bull 1992;112:155-159
27. Davis JC, Revicki D, van der Heijde DMF, Rentz AM, Wong RL, Kupper H, et al. Health-related quality of life outcomes in patients with active ankylosing spondylitis treated with adalimumab: results from a randomized controlled study. Arthritis Rheum 2007;57:1050-1057
28. Ward MM. Outcome measurement: health status and quality of life. Curr Opin Rheumatol 2004;16:96-101. (Pubitemid 38280942)
29. Rustoen T, Wahl A, Hanestad B, Lerdal A, Paul S, Miaskowski C. Gender differences in chronic pain - findings from a population-based study of Norwegian adults. Pain Manag Nurs 2004;5:105-117 (Pubitemid 40533044)
30. Hays RD, Brodsky M, Johnston MF, Spritzer KL, Hui KK. Evaluating the statistical significance of health-related quality of life change in individual patients. Eval Health Prof 2005;28:160-171 (Pubitemid 40628905)
31. Gonzalez-Lopez L, Garcia-Gonzalez A, Vazquez-Del-Mercado M, Munoz-Valle JF, Gamez-Nava JI. Efficacy of methotrexate in ankylosing spondylitis: a randomized, double blind, placebo controlled trial. J Rheumatol 2004;31:1568-1574 (Pubitemid 39006639)
32. Ortiz Z, Shea B, Garcia Dieguez M, Boers M, Tugwell P, Boonen A, et al. The responsiveness of generic quality of life instruments in rheumatic diseases. A systematic review of randomized controlled trials. J Rheumatol 1999;26:210-216 (Pubitemid 29051423)
33. Revicki D, Hays RD, Cella D, Sloan J. Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. J Clin Epidemiol 2008;61:102-109
34. Hays RD, Farivar S, Liu H. Approaches and recommendations for estimating minimally important differences for health-related quality of life measures. COPD 2005;2:63-67 (Pubitemid 40776225)
35. Khanna D, Tsevat J. Health-related quality of life - an introduction. Am J Manag Care 2007;13:S218-23.
36. Aletaha D, Smolen J, Ward MM. Measuring function in rheumatoid arthritis: identifying reversible and irreversible components. Arthritis Rheum 2006;54:2784-2792 (Pubitemid 44497757)
37. Shinjo SK, Goncalves R, Kowalski S, Goncalves CR. Brazilian-Portuguese version of the Health Assessment Questionnaire for Spondyloarthropathies (HAQ-S) in patients with ankylosing spondylitis: a translation, cross-cultural adaptation, and validation. Clin Rheumatol 2007;26:1254-1258 (Pubitemid 47034178)